Condition
Ischemic Mitral Regurgitation clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Ischemic Mitral Regurgitation clinical trials that are recruiting, at sites in 2 countries (most in Canada (1), China (1)). By phase: Phase 2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Sacubitril/valsartan after bypass to treat moderate ischemic mitral regurgitation
This trial will test whether the drug sacubitril/valsartan can reduce moderate ischemic mitral regurgitation in people with coronary artery disease who have had isolated coronary artery bypass grafting (CABG).
-
Using cyproheptadine to treat ischemic mitral regurgitation
This study is testing if cyproheptadine can help people with ischemic mitral regurgitation after a heart attack by looking at changes in their heart and valve function.
Related topics
Quick answers
How many Ischemic Mitral Regurgitation clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Canada (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.